Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors

Local hypoxia in tumors is an undesirable consequence of photodynamic therapy (PDT), which will lead to greatly reduced effectiveness of this therapy. Bioreductive pro‐drugs that can be activated at low‐oxygen conditions will be highly cytotoxic under hypoxia in tumors. Based on this principle, doub...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition 2015-07, Vol.54 (28), p.8105-8109
Main Authors: Liu, Yanyan, Liu, Yong, Bu, Wenbo, Cheng, Chao, Zuo, Changjing, Xiao, Qingfeng, Sun, Yong, Ni, Dalong, Zhang, Chen, Liu, Jianan, Shi, Jianlin
Format: Article
Language:English
Subjects:
Activated
Animals
bioreductive pro-drugs
Cell Hypoxia - physiology
Cytotoxicity
Effectiveness
Humans
Hypoxia
Mice
Nanoparticles
Nanoparticles - metabolism
Neoplasms - therapy
Photochemotherapy - methods
Photodynamic therapy
Photosensitizing Agents - therapeutic use
synergetic therapy
Therapy
Tumors
Upconversion
upconversion nanoparticles
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Local hypoxia in tumors is an undesirable consequence of photodynamic therapy (PDT), which will lead to greatly reduced effectiveness of this therapy. Bioreductive pro‐drugs that can be activated at low‐oxygen conditions will be highly cytotoxic under hypoxia in tumors. Based on this principle, double silica‐shelled upconversion nanoparticles (UCNPs) nanostructure capable of co‐delivering photosensitizer (PS) molecules and a bioreductive pro‐drug (tirapazamine, TPZ) were designed (TPZ‐UC/PS), with which a synergetic tumor therapeutic effect has been achieved first by UC‐based (UC‐) PDT under normal oxygen environment, immediately followed by the induced cytotoxicity of activated TPZ when oxygen is depleted by UC‐PDT. Treatment with TPZ‐UC/PS plus NIR laser resulted in a remarkably suppressed tumor growth as compared to UC‐PDT alone, implying that the delivered TPZ has a profound effect on treatment outcomes for the much‐enhanced cytotoxicity of TPZ under PDT‐induced hypoxia. Synergetic therapy: Strong hypoxia created by upconversion photodynamic therapy (UC‐PDT) activates bioreductive pro‐drugs co‐delivered to form cytotoxic species, thereby potentiating the synergetic anticancer efficacy of UC‐PDT. This process was accomplished by using upconversion‐based nanoparticles designed to simultaneously deliver photosensitizer molecules and bioreductive pro‐drugs in silica layers.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.201500478